PGEN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Zero Revenue FULTP Q1 2026 Earnings EPS Beats Estimates Preferred Stock Declines Slightly BBAI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy RCMT Q1 2026 Earnings EPS Misses Analyst Expectations as Stock Rebounds CANF Q4 2023 Earnings Narrower Loss Surprises Amid PreRevenue Stage